These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

780 related articles for article (PubMed ID: 27880667)

  • 21. The place for itraconazole in treatment.
    Maertens J; Boogaerts M
    J Antimicrob Chemother; 2005 Sep; 56 Suppl 1():i33-i38. PubMed ID: 16120632
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antifungal treatment strategies in patients with haematological diseases or cancer: from prophylaxis to empirical, pre-emptive and targeted therapy.
    Mikolajewska A; Schwartz S; Ruhnke M
    Mycoses; 2012 Jan; 55(1):2-16. PubMed ID: 21554421
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A retrospective cohort of invasive fusariosis in the era of antimould prophylaxis.
    Fernández-Cruz A; Semiglia MA; Guinea J; Martínez-Jiménez MDC; Escribano P; Kwon M; Rodríguez-Macías G; Chamorro-de-Vega E; Rodríguez-González C; Navarro R; Galar A; Sánchez-Carrillo C; Díez-Martín JL; Muñoz P
    Med Mycol; 2020 Apr; 58(3):300-309. PubMed ID: 31231772
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Isavuconazole for treatment of invasive fungal diseases caused by more than one fungal species.
    Marty FM; Cornely OA; Mullane KM; Ostrosky-Zeichner L; Maher RM; Croos-Dabrera R; Lu Q; Lademacher C; Oren I; Schmitt-Hoffmann AH; Giladi M; Rahav G; Perfect JR
    Mycoses; 2018 Jul; 61(7):485-497. PubMed ID: 29611227
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical considerations in the early treatment of invasive mould infections and disease.
    Mercier T; Maertens J
    J Antimicrob Chemother; 2017 Mar; 72(suppl_1):i29-i38. PubMed ID: 28355465
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Radiologic findings of Fusarium pneumonia in neutropenic patients.
    Sassi C; Stanzani M; Lewis RE; Vianelli N; Tarsi A; Poerio A; Cavo M; Battista G
    Mycoses; 2017 Feb; 60(2):73-78. PubMed ID: 27470138
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pulmonary mucormycosis.
    Hamilos G; Samonis G; Kontoyiannis DP
    Semin Respir Crit Care Med; 2011 Dec; 32(6):693-702. PubMed ID: 22167397
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Disseminated mucormycosis masquerading as rejection early after orthotopic heart transplantation.
    Margoles L; DeNofrio D; Patel AR; Golan Y; Vest AR; Arkun K; Boucher HW; Kiernan MS; Upshaw JN
    Transpl Infect Dis; 2018 Feb; 20(1):. PubMed ID: 29172240
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Disseminated fusariosis in immunocompromised children: a case series and review of literature.
    Riojas Hernández MP; Cisneros Saldaña D; Vaquera Aparicio DN; Castillo Bejarano JI; Mascareñas de Los Santos AH; Villanueva-Lozano H; Treviño-Rangel Rogelio de J; De la O Cavazos ME
    J Chemother; 2021 Dec; 33(8):519-527. PubMed ID: 33563140
    [TBL] [Abstract][Full Text] [Related]  

  • 30. 2016 guideline strategies for the use of antifungal agents in patients with hematological malignancies or hematopoietic stem cell transplantation recipients in Taiwan.
    Ko BS; Chen WT; Kung HC; Wu UI; Tang JL; Yao M; Chen YC; Tien HF; Chang SC; Chuang YC; Lin DT; ; ; ; ; ;
    J Microbiol Immunol Infect; 2018 Jun; 51(3):287-301. PubMed ID: 28781151
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interpretation, pitfalls of biomarkers in diagnosis of invasive fungal diseases.
    Lass-Florl C; Alastruey-Izquierdo A; Gupta R; Chakroborti A
    Indian J Med Microbiol; 2022; 40(4):480-484. PubMed ID: 35970627
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Complications of invasive mycoses in organ transplant recipients.
    Samanta P; Singh N
    Expert Rev Anti Infect Ther; 2016 Dec; 14(12):1195-1202. PubMed ID: 27690694
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Defining standards of CARE for invasive fungal diseases in adult haematology patients: antifungal prophylaxis versus treatment.
    Barnes R; Rogers T; Maertens J
    J Antimicrob Chemother; 2019 Mar; 74(Suppl 2):ii21-ii26. PubMed ID: 31222310
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Therapeutic Challenges of Non-
    Lamoth F; Kontoyiannis DP
    Antimicrob Agents Chemother; 2019 Nov; 63(11):. PubMed ID: 31481441
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antifungal stewardship in invasive Candida infections.
    Ruhnke M
    Clin Microbiol Infect; 2014 Jun; 20 Suppl 6():11-8. PubMed ID: 24661820
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Active Surveillance Program to Increase Awareness on Invasive Fungal Diseases: the French RESSIF Network (2012 to 2018).
    Bretagne S; Sitbon K; Desnos-Ollivier M; Garcia-Hermoso D; Letscher-Bru V; Cassaing S; Millon L; Morio F; Gangneux JP; Hasseine L; Favennec L; Cateau E; Bailly E; Moniot M; Bonhomme J; Desbois-Nogard N; Chouaki T; Paugam A; Bouteille B; Pihet M; Dalle F; Eloy O; Sasso M; Demar M; Mariani-Kurkdjian P; Robert V; Lortholary O; Dromer F;
    mBio; 2022 Jun; 13(3):e0092022. PubMed ID: 35499498
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dynamics and prognostic value of plasma cell-free DNA PCR in patients with invasive aspergillosis and mucormycosis.
    Moreno A; Mah J; Budvytiene I; Ho DY; Schwenk HT; Banaei N
    J Clin Microbiol; 2024 May; 62(5):e0039424. PubMed ID: 38602412
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Practical issues related to non-Aspergillus invasive mold infections.
    Nucci M; Nouér SA
    Mol Aspects Med; 2023 Dec; 94():101230. PubMed ID: 38011770
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Galactomannan testing might be useful for early diagnosis of fusariosis.
    Mikulska M; Furfaro E; Del Bono V; Gualandi F; Raiola AM; Molinari MP; Gritti P; Sanguinetti M; Posteraro B; Bacigalupo A; Viscoli C
    Diagn Microbiol Infect Dis; 2012 Apr; 72(4):367-9. PubMed ID: 22280997
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical characteristics and treatment outcomes of pulmonary invasive fungal infection among adult patients with hematological malignancy in a medical centre in Taiwan, 2008-2013.
    Chen CY; Sheng WH; Tien FM; Lee PC; Huang SY; Tang JL; Tsay W; Tien HF; Hsueh PR
    J Microbiol Immunol Infect; 2020 Feb; 53(1):106-114. PubMed ID: 29449166
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 39.